Berman Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$123K Buy
511
+119
+30% +$30K 0.02% 383
2021
Q2
$92K Buy
392
+117
+43% +$26.7K 0.01% 409
2021
Q1
$59K Buy
275
+119
+76% +$23.9K 0.01% 426
2020
Q4
$27K Buy
156
+17
+12% +$2.94K 0.01% 588
2020
Q3
$21K Buy
139
+3
+2% +$475 0.01% 569
2020
Q2
$19K Sell
136
-71
-34% -$9.82K 0.01% 558
2020
Q1
$21K Sell
207
-27
-12% -$3.89K 0.01% 480
2019
Q4
$34K Hold
234
0.01% 404
2019
Q3
$33K Hold
234
0.01% 384
2019
Q2
$34K Buy
234
+62
+36% +$8.65K 0.01% 382
2019
Q1
$22K Buy
172
+130
+310% +$16K 0.01% 431
2018
Q4
$4K Buy
+42
New +$5.63K ﹤0.01% 745

Other funds holding LH

Berman Capital Advisors's LH Position: Q3 2021 in Review

Berman Capital Advisors increased its Labcorp (LH) stake by 30% in Q3 2021, buying an estimated $30K and bringing the position to 511 shares worth $123K. The position accounts for 0.02% of the portfolio, ranked #383.

Berman Capital Advisors first reported a position in LH in Q4 2018 and has held it in 12 quarters since. 993 funds tracked by Wall St. Rank hold LH as of Q3 2021.

  • Berman Capital Advisors held 511 shares of Labcorp worth $123K as of Q3 2021.
  • Berman Capital Advisors bought 119 Labcorp shares in Q3 2021, an estimated $30K.
  • Labcorp made up 0.02% of Berman Capital Advisors's portfolio in Q3 2021, its #383 holding.
  • Berman Capital Advisors first reported a position in Labcorp in Q4 2018 and has held it in 12 quarters since.
  • 993 funds tracked by Wall St. Rank held Labcorp as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.